Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02253173 · ClinicalTrials.gov registry record · Phase 3
Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women
A Phase 3 study, sponsored by TherapeuticsMD.
- Completed
- Registry status
- Phase 3
- Development phase
- 764
- Enrollment target
NCT02253173: Completed Phase 3 study, sponsored by TherapeuticsMD.
NCT02253173 is a Phase 3 study that has completed, run by TherapeuticsMD. The registered enrollment target is 764 participants, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02253173, a Phase 3 study, has completed, sponsored by TherapeuticsMD.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 764 participants
- Enrollment target
Study Summary
This study will assess the safety and efficacy of a new formulation of vaginal estradiol for the treatment of symptoms of vulvar and vaginal atrophy in postmenopausal women.
Primary Outcome
• Change from Baseline to Week 12 in the percentage of vaginal superficial cells (by vaginal cytologic smear) compared to placebo
Interventions
- DRUG Placebo
- DRUG Estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 764 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-10 |
| Phase | Phase 3 |
What the finished NCT02253173 record still lists
NCT02253173 is an interventional study that assigns participants to a tested intervention. The registered 764 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02253173 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02253173 about?
NCT02253173 is a clinical study titled "Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women". This study will assess the safety and efficacy of a new formulation of vaginal estradiol for the treatment of symptoms of vulvar and vaginal atrophy in postmenopausal women.
What is the current status of trial NCT02253173?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 764 participants. The study started on 2014-09. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02253173?
The interventions under investigation include: Placebo (DRUG), Estradiol (DRUG).
Who is sponsoring clinical trial NCT02253173?
This trial is sponsored by TherapeuticsMD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02253173's enrollment target sits among peer trials
764 449th of 2000 higher than 1,552 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578665 · 764 participants · NA
Human-like Robotic Controllers for Enhanced Motor Learning
- NCT05579366 · 764 participants · Phase 1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- NCT03789552 · 765 participants · Phase 3
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
- NCT07195591 · 766 participants · Phase 3
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia